Filing Details

Accession Number:
0001104659-19-076800
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-30 16:33:29
Reporting Period:
2019-12-26
Accepted Time:
2019-12-30 16:33:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1273636 Applied Genetic Technologies Corp AGTC Biological Products, (No Disgnostic Substances) (2836) 593553710
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1737272 B.v. Visions Inspirational Gustav Mahlerplein 3
Amsterdam P7 1082 MS
No No Yes No
1771821 2.0 Aescap Stichting Gustav Mahlerplein 3
Amsterdam P7 1082 MS
No No Yes No
1795073 Hendrik Johan Patrick Krol Gustav Mahlerplein 3
Amsterdam P7 1082 MS
No No Yes No
1795097 B.v. Management Fund Privium Gustav Mahlerplein 3
Amsterdam P7 1082 MS
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-12-26 81,162 $5.24 1,780,762 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 24,999 Indirect See footnote
Footnotes
  1. Stichting Aescap 2.0's ("Aescap 2.0") sale of AGTC common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 2,544 shares, with Aescap 2.0's purchase of 2,544 shares of AGTC common stock at a price of $2.79 per share on November 19, 2019. Aescap 2.0 has agreed to pay to AGTC, upon settlement of the sale, $6,217.00, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs.
  2. Shares of Common Stock held directly by Aescap 2.0. Privium Fund Management B.V. ("Privium") is the fund manager of Aescap 2.0 and may be deemed to beneficially own the shares held by Aescap 2.0. Patrick Johan Hendrik Krol ("Krol") is the portfolio manager of Privium and may be deemed to beneficially own the shares held by Aescap 2.0. Each of Privium and Krol disclaims beneficial ownership of all the shares held by Aescap 2.0 except to the extent of each of their pecuniary interest therein.
  3. Shares of Common Stock held directly by Inspirational Visions BV ("Inspirational Visions"). Krol is the managing director of Inspirational Visions and may be deemed to beneficially own the shares held by Inspirational Visions.